Psychopharmacologia

, Volume 25, Issue 1, pp 14–21

A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant

  • H. M. van Praag
  • J. Korf
  • L. C. W. Dols
  • T. Schut
Human Pharmacology

Abstract

In depressions, varying therapeutic effects have been obtained with 5-HT precursors. This is possibly due to the fact that the group of the depressions is pathogenetically heterogeneous; that, specifically, some types do and other types do not entail disturbances in the central 5-HT metabolism; and that only the former types are “precursor-sensitive”. This hypothesis was tested in a preliminary pilot study, and confirmed. The central 5-HT consumption was assessed on the basis of the probenecid test. In this experiment, 5-HTP was for the first time given in large doses over a considerable period of time.

Key words

Depression Serotonin Hypothesis Probenecid Test 5-Hydroxytryptophan Antidepressants 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ashcroft, G. W., Crawford, T. B. B., Eccleston, D., Sharman, D. F., Mac- Dougall, E. J., Stanton, J. B., Binns, J. K.: 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet 1966 II, 1049.Google Scholar
  2. Bourne, H. R., Bunney, W. E., Colburn, R. W., Davis, J. M., Davis, J. N., Shaw, D. M., Coppen, A. J.: Noradrenaline, 5-hydroxytryptamine and 5-hydroxy indoleacetic acid in hind brains of suicidal patients. Lancet 1968 II, 805.Google Scholar
  3. Carroll, B. J., Mowbray, R. M., Davies, B.: Sequential comparison of l-tryptophan with E.C.T. in severe depression. Lancet 1970 I, 967.Google Scholar
  4. Coppen, A., Shaw, D. M., Farrel, J. P.: Potentiation of the antidepressive effect of a monoamine oxidase inhibitor by tryptophan. Lancet 1963 I, 79.Google Scholar
  5. —, Herzberg, B., Maggs, R.: Tryptophan in the treatment of depression. Lancet 1967 II, 1178.Google Scholar
  6. Kline, N. S., Sacks, W., Simpson, G. M.: Further studies on: one day treatment of depression with 5-HTP. Amer. J. Psychiat. 121, 379 (1964).Google Scholar
  7. Korf, J., Praag, H. M. van: Amine metabolism in the human brain: further evaluation of the probenecid test. Brain Res. 35, 221 (1971).Google Scholar
  8. —, Sebens, J. B.: Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid. Biochem. Pharmacol. 20, 659 (1971).Google Scholar
  9. Lakke, J. P. W. F., Korf, J., Praag, H. M. van, Schut, T.: The predictive value of the probenecid test for the effect of levodopa therapy in Parkinson disease. Nature (Lond.) (in press).Google Scholar
  10. Pare, C. M. B., Sandler, M. J.: Clinical and biochemical study of a trial of iproniazid in the treatment of depression. J. Neurol. Neurosurg. Psychiat. 22, 247 (1959).Google Scholar
  11. —, Yeung, D. P. H., Price, K., Stacey, R. S.: 5-Hydroxytryptamine, noradrenaline and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning. Lancet 1969 II, 133.Google Scholar
  12. Persson, T., Roos, B.-E.: 5-Hydroxytryptophan for depression. Lancet 1967 II, 987.Google Scholar
  13. Praag, H. M. van: A critical investigation into the possible significance of monoamine oxidase inhibition as the therapeutic principle in the treatment of depressions. Thesis, Utrecht 1962.Google Scholar
  14. —, Korf, J.: A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients. Biol. Psychiat. 3, 105 (1971).Google Scholar
  15. —: Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: a biochemical classification? Psychopharmacologia (Berl.) 19, 148 (1971).Google Scholar
  16. —, Puite, J.: The influence of probenecid on the concentration of 5-hydroxyindoleacetic acid in the cerebrospinal fluid in depressive patients. Nature (Lond.) 225, 1259 (1970).Google Scholar
  17. Roos, B.-E., Sjöström, R.: 5-Hydroxyindoleacetic acid (and homovanillic acid) levels in the cerebrospinal fluid after probenecid application in patients with manic-depressive psychosis. Pharmacol. Clin. 1, 153 (1969).Google Scholar
  18. Shaw, D. M., Camps, F. E., Eccleston, E. C.: 5-Hydroxytryptamine in the hind brain of depressive suicides. Brit. J. Psychiat. 113, 1407 (1967).Google Scholar
  19. Tamarkin, N. R., Goodwin, F. K., Axelrod, J.: Rapid elevation of biogenic amine metabolites in human CSF following probenecid. Life Sci. 9, 1397 (1970).Google Scholar

Copyright information

© Springer-Verlag 1972

Authors and Affiliations

  • H. M. van Praag
    • 1
  • J. Korf
    • 1
  • L. C. W. Dols
    • 1
  • T. Schut
    • 1
  1. 1.Department of Biological Psychiatry and Department of Clinical PsychologyPsychiatric University ClinicGroningenThe Netherlands

Personalised recommendations